+987.9%
MRNA vs COPX
+31.7%
+956.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | COPX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +4.0% | +9.1% | +10.3% |
| 7D | +20.6% | -3.0% | +23.6% | +23.2% |
| 30D | +27.1% | -13.6% | +40.8% | +41.1% |
| 3M | +353.4% | -11.2% | +364.6% | +396.0% |
| 6M | +446.3% | -2.4% | +448.7% | +461.8% |
| YTD | +776.2% | +4.2% | +772.0% | +757.0% |
| 1Y | +987.9% | +32.2% | +955.7% | +752.9% |
| All | +987.9% | +31.7% | +956.2% | +752.9% |
Cumulative growth
Daily Returns
Daily percentage return beside COPX.
Daily Out/Under-Performance
Portfolio return minus COPX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × COPX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded COPX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling